poisar

Stocks · News reference

8-K filing — Rani Therapeutics Holdings, Inc. (RANI)

SEC EDGARSEC EDGAR

Filed: 2026-08-13 AccNo: 0001193125-26-349197 Size: 469 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Newsdesk

    Rani Therapeutics Joins FDA Emerging Technology Platform

    Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the RaniPill® Capsule™ platform technology has been accepted into the